Overview
Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System
Description
The study is a multi-center, prospective, single arm study designed to evaluate the safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System
Eligibility
Inclusion Criteria:
- Functional or degenerative TR moderate or greater
- Symptomatic despite medical therapy
- The Local Site Heart Team determines that the patient is appropriate for transcatheter tricuspid valve replacement
Exclusion Criteria:
- Unsuitable anatomy
- Previous tricuspid valve repair or replacement
- Comorbid condition(s) that, in the opinion of the investigator, could limit the patient's ability to participate in the study, including compliance with follow- up requirements, or that could impact the scientific integrity of the study.